Global Hemp Group Inc.

Equities

GHG

CA37953Y2033

Healthcare Facilities & Services

Delayed Canadian Securities Exchange Other stock markets 03:57:07 2024-04-15 pm EDT			5-day change	1st Jan Change
0.045 ^CAD	-25.00%		-.--%	-30.77%

Jan. 16	Global Hemp Group Inc. cancelled the transaction announced on January 15, 2024	CI
Jan. 15	Global Hemp Group Inc. announced that it expects to receive CAD 0.75 million in funding	CI

Hemp: A Sustainable Powerhouse with Endless Uses

March 14, 2024 at 12:25 pm EDT

Hemp, a remarkable plant is a member of the Cannabis sativa family, is emerging as a champion for a sustainable future. Unlike its close relative, marijuana, hemp boasts a low environmental footprint, requiring minimal water and no pesticides to thrive. This makes it a promising alternative for eco-conscious practices. [...]

This is an abstract of the document. To keep reading, click here and get access to the original version.

Attachments

Original Link
Permalink

Disclaimer

Global Hemp Group Inc. published this content on 14 March 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 14 March 2024 16:24:08 UTC.

Latest news about Global Hemp Group Inc.

Global Hemp Group Inc. cancelled the transaction announced on January 15, 2024	Jan. 15	CI
Global Hemp Group Inc. announced that it expects to receive CAD 0.75 million in funding	Jan. 14	CI
Global Hemp Group Inc. Announces Resignation of Stephen Barnhill Jr. as Director	Jan. 12	CI
Global Hemp Group Inc. Appoints Yousef Kamhiyah as Chief Financial Officer	Jan. 12	CI
Global Hemp Group Inc. Announces Resignation of Veronique Laberge as CFO	Jan. 08	CI
Global Hemp Group Inc. Announces Resignation of Veronique Laberge as Director	Jan. 08	CI
Global Hemp Group Inc. announced that it expects to receive CAD 0.448537 million in funding	23-10-15	CI
Global Hemp Group Inc. Executes Letter of Intent with B-Organic R&D Corp. to Establish 50% Joint Venture with its Patented Bioactive Lipid Agents Technology	23-10-11	CI
Global Hemp Group Inc. Appoints Ramsey Douglas as Director	23-10-03	CI
Global Hemp Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-28	CI
Global Hemp Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-29	CI
Global Hemp Group Inc. announced that it has received CAD 1 million in funding	23-04-19	CI
Global Hemp Group Inc. Appoints Jeff Nagel as Product Manufacturing Advisor	23-03-29	CI
Global Hemp Group Announces the Appointment of Dr. Herbert Fritsche to the Advisory Board as Its Chief Scientific Advisor	23-03-22	CI
Global Hemp Group Inc. Announces Executive Changes	23-03-20	CI
Global Hemp Group Inc. Announces Management Changes	23-03-20	CI
Global Hemp Group Inc. announced that it expects to receive CAD 0.75 million in funding	23-03-07	CI
Global Hemp Group Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-03-01	CI
Global Hemp Group Inc. Appointment of Arelio Useche and Veronique Laberge as Board of Directors	23-02-14	CI
Global Hemp Group Inc. Auditor Raises 'Going Concern' Doubt	23-02-05	CI
Global Hemp Group Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-02-05	CI
Revitalize Earth cancelled the acquisition of Global Hemp Group Inc. (CNSX : GHG) in a reverse merger transaction.	23-01-02	CI
Global Hemp Group Inc. Announces Resignation of Michel Lebeuf as Director	22-11-04	CI
Global Hemp Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-28	CI
Revitalize Earth entered into letter of intent to acquire Global Hemp Group Inc. (CNSX : GHG) for CAD 5.4 million in a reverse merger transaction.	22-07-12	CI

Chart Global Hemp Group Inc.

Duration

Period

More charts

Company Profile

Global Hemp Group Inc. is a Canada-based company, which is focused on developing and promoting hemp-based products. The Company operates through two segments: BioPharma Division and Industrial Hemp Division. BioPharma Division has executed a Letter of Intent (LOI) with B-Organic R&D Corp. (B-Organic) to license its Bioactive Lipid Agents (BLA) technology, a patented matrix, which is able to increase the solubility and bioavailability of various poorly soluble pharma ingredients, including cannabinoids. Industrial Hemp Division is involved in the development and promotion of hemp-based products. The Companyâs has acquired the perpetual license for North America (the United States, Canada and Mexico) to certain Apollon Intellectual Property and proprietary technology.

Sector

Healthcare Facilities & Services

Calendar

2024-05-27 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Medical Farming

	1st Jan change	Capi.
GLOBAL HEMP GROUP INC.	-30.77%	799K
AYR WELLNESS INC.	+51.44%	289M
ASCEND WELLNESS HOLDINGS, INC.	+31.96%	270M
ORGANIGRAM HOLDINGS INC.	+50.58%	193M
INTERCURE LTD.	+173.38%	148M
IANTHUS CAPITAL HOLDINGS, INC.	-14.29%	145M
JUSHI HOLDINGS INC.	+54.76%	143M
THE CANNABIST COMPANY HOLDINGS INC.	-31.90%	142M
4FRONT VENTURES CORP.	0.00%	80.17M
BAKHU HOLDINGS, CORP.	+150.00%	75.33M

Medical Farming